Abstract

Cannabis use is increasing globally, yet the immunological effects of Δ9-tetrahydrocannabinol, the main intoxicating component of cannabis, remain incompletely understood. Given prior evidence that endocannabinoid signaling influences helminth immunity and type 2 inflammation, we investigated how sustained Δ9-tetrahydrocannabinol exposure alters immune responses to the helminth Nippostrongylus brasiliensis, which infects the lung and small intestine of mice. C57BL/6J mice were treated with Δ9-tetrahydrocannabinol (5 mg/kg/d) or vehicle for 14 d prior to helminth infection and assessed for parasite burden, innate immune cell and T cell responses, and transcriptional changes in lung eosinophils and macrophages. Δ9-Tetrahydrocannabinol exposure did not significantly alter infection-associated weight loss or helminth burden; however, Δ9-tetrahydrocannabinol selectively restrained infection-induced circulating eosinophils and monocytes while increasing regulatory T cells. T cell activation assays showed reduced TNFα and IFNγ secretion in splenocytes from Δ9-tetrahydrocannabinol-treated infected mice. Bulk RNA sequencing showed that Δ9-tetrahydrocannabinol shifted lung eosinophils and CD11c+ lung macrophage-enriched cells from inflammatory, fibrotic, and costimulatory pathways toward stress and metabolic-adaptive transcriptional programs. Within the infected macrophage-enriched population, Δ9-tetrahydrocannabinol reduced CD80 expression while increasing MHC class II and antigen presentation-associated genes, suggesting a potential shift in macrophage-mediated T cell activation. Consistent with altered inflammatory and tissue remodeling-associated programs, immunofluorescent staining showed that Δ9-tetrahydrocannabinol mitigated infection-associated loss of lung collagen. Collectively, these findings indicate that Δ9-tetrahydrocannabinol reshapes the immune response to helminth infection by restraining innate and T cell effector responses while altering lung eosinophil and macrophage activation programs.

Authors

Jennett J, Olmos M, Lam KM, Midou S, DiPatrizio NV, Nair MG

Topics and compounds

THCendocannabinoid systemTHCendocannabinoid system

Continue with the source

Open original record ↗